Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ANADYS PHARMACEUTICALS INC Financial Overview

  • Income Statement: ANDS

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 0.00 24.12 M -24.12 M -∞ T%
    Gross Profit -1.14 M 22.69 M -23.83 M 2,088.34%
    Net Income Before Extra Items/Preferred Div -32.40 M -9.17 M -23.23 M 71.69%
    Operating Income -34.10 M -12.77 M -21.34 M 62.57%
  • Cash Flow: ANDS

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 259,000.00 257,000.00 2,000.00 0.77%
    Net Cash Flow - Investing -3.84 M 2.32 M -6.15 M 160.40%
    Net Cash Flow/Operating Activities -28.29 M -25.66 M -2.63 M 9.30%
  • Balance Sheet: ANDS

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 31.67 M 61.53 M -29.85 M -94.25%
    Total Liabilities 5.85 M 5.85 M 2,000.00 0.03%
    Shareholders Equity 25.82 M 55.68 M -29.85 M -115.60%
  • Key Ratios / Statistics: ANDS

    • Valuation

      Price/Earnings (TTM) -1.39
      Price/Sales (TTM) 1.91
      Price/Book (MRQ) 5.37
      Price/Cash Flow (TTM) -2.52
    • Profitability

      Gross Margin 94.07
      Operating Margin -52.93
      Profit Margin -38.03
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 4.85
      Current Ratio (MRQ) 2.95
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -79.68
      Return on Assets (TTM) -95.47
      Return on Investments (TTM) -79.51